Femasys (FEMY) Non Operating Income (2020 - 2025)
Femasys (FEMY) posted Non Operating Income of -$734356.0 for Q2 2025, down 66.74% on a QoQ basis from -$440420.0 in Q1 2025, and down 259.67% year-over-year from $459911.3 in Q2 2024.
Femasys (FEMY) Non Operating Income (2020 - 2025) Analysis & Trends
Femasys' Non Operating Income history runs 6 years deep, the most recent figure standing at -$734356.0 for Q2 2025.
- Quarterly Non Operating Income fell 259.67% year-over-year to -$734356.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$1.9 million (down 769.72% YoY) and the FY2025 annual result came in at -$1.0 million, down 1.64% from the prior year.
- Non Operating Income was -$734356.0 for Q2 2025 at Femasys, down from -$440420.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $818016.0 in Q2 2021 and bottomed at -$802308.0 in Q4 2021.
- A 5-year average of -$94863.4 and a median of $906.5 in 2021 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 45095.38% in 2021, while the deepest fall reached 389569.9% in 2021.
- Femasys' Non Operating Income stood at -$802308.0 in 2021, then jumped by 112.82% to $102822.0 in 2022, then plunged by 57.79% to $43399.0 in 2023, then plunged by 1000.75% to -$390918.0 in 2024, then tumbled by 87.85% to -$734356.0 in 2025.
- Business Quant data shows FEMY's Non Operating Income at -$734356.0 in Q2 2025, -$440420.0 in Q1 2025, and -$390918.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -131.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 12.29 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 3.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -62.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.93 Mn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -734,356.00 |
| Mar 31, 2025 | -440,420.00 |
| Dec 31, 2024 | -390,918.00 |
| Sep 30, 2024 | -289,262.00 |
| Jun 30, 2024 | -204,173.00 |
| Mar 31, 2024 | -136,868.00 |
| Dec 31, 2023 | 43,399.00 |
| Sep 30, 2023 | 84,359.00 |
| Jun 30, 2023 | 42,454.00 |
| Mar 31, 2023 | 97,089.00 |
| Dec 31, 2022 | 102,822.00 |
| Sep 30, 2022 | 74,346.00 |
| Jun 30, 2022 | 26,745.00 |
| Mar 31, 2022 | -280.00 |
| Dec 31, 2021 | -802,308.00 |
| Sep 30, 2021 | 1,649.00 |
| Jun 30, 2021 | 818,016.00 |
| Mar 31, 2021 | 164.00 |
| Dec 31, 2020 | 206.00 |
| Sep 30, 2020 | -3,418.00 |